World news, news around town, tech update 3
Ad
Thursday, 23 August 2018
AstraZeneca inhaler lags GSK drug in lung disease trial
A new AstraZeneca inhaler for chronic lung disease has proved worse than a rival GlaxoSmithKline product in a clinical trial, a result AstraZeneca said was inconsistent with earlier findings.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment